Editorial
Published on 21 Dec 2023
Editorial: Insights in PET and SPECT: 2023
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1342672
- 1,123 views
Type at least 3 characters
109 articles
Perspective
Published on 14 Dec 2023
Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1291253
- 4,898 views
- 6 citations
![Utilizing MRI, [18F]FDG-PET and [89Zr]Zr-DFO-28H1 FAP-PET tracer to assess inflammation and fibrogenesis in a reproducible lung injury rat model: a multimodal imaging study](https://www.frontiersin.org/files/myhome article library/1306251/1306251_Thumb_400.jpg)
Original Research
Published on 12 Dec 2023
Utilizing MRI, [18F]FDG-PET and [89Zr]Zr-DFO-28H1 FAP-PET tracer to assess inflammation and fibrogenesis in a reproducible lung injury rat model: a multimodal imaging study
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1306251
- 2,074 views
- 5 citations
![Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases](https://www.frontiersin.org/files/myhome article library/1343913/1343913_Thumb_400.jpg)
Editorial
Published on 11 Dec 2023
Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1343913
- 1,482 views
Original Research
Published on 06 Dec 2023
A fast Monte Carlo cell-by-cell simulation for radiobiological effects in targeted radionuclide therapy using pre-calculated single-particle track standard DNA damage data
in Radionuclide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1284558
- 1,692 views
- 2 citations
Case Report
Published on 27 Nov 2023
Case Report: Post-traumatic splenosis and potential pitfall for PSMA-PET
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1319952
- 1,291 views
Editorial
Published on 27 Nov 2023
Editorial: Prof. Frank Rösch's legacy in the radiopharmaceutical chemistry field
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1336481
- 1,019 views
![Effects of dynamic [18F]NaF PET scan duration on kinetic uptake parameters in the knee](https://www.frontiersin.org/files/myhome article library/1194961/1194961_Thumb_400.jpg)
Original Research
Published on 24 Nov 2023
Effects of dynamic [18F]NaF PET scan duration on kinetic uptake parameters in the knee
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1194961
- 1,441 views
- 1 citation
Editorial
Published on 10 Nov 2023
Editorial: Rising stars in PET and SPECT: 2022
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1326549
- 1,059 views
Case Report
Published on 26 Oct 2023
First use of 18F-FDG PET in TEMPI syndrome: can it be used for treatment assessment? A case report
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1273967
- 1,492 views
Review
Published on 25 Oct 2023
Emerging theragnostic radionuclide applications for hepatocellular carcinoma
in Radionuclide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1210982
- 2,756 views
- 3 citations
Hypothesis and Theory
Published on 13 Oct 2023
Radiopharmaceutical administration practices—Are they best practice?
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1244660
- 3,490 views
- 3 citations
Mini Review
Published on 09 Oct 2023
Mini review of first-in-human integrin αvβ6 PET tracers
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1271208
- 3,623 views
- 5 citations
![[18F]NaF PET/CT imaging of response to single fraction SABR to bone metastases from breast cancer](https://www.frontiersin.org/files/myhome article library/1197397/1197397_Thumb_400.jpg)
Brief Research Report
Published on 04 Oct 2023
[18F]NaF PET/CT imaging of response to single fraction SABR to bone metastases from breast cancer
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1197397
- 1,583 views
- 1 citation
Review
Published on 21 Sep 2023
Evaluation of deep space exploration risks and mitigations against radiation and microgravity
in Dosimetry and Radiation Safety
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1225034
- 9,660 views
- 12 citations
Original Research
Published on 20 Sep 2023
Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1184309
- 2,225 views